A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome

NCT04933292 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Hepatitis
Primary Biliary Cirrhosis

Interventions

DRUG: Methylprednisolone and Mycophenolate mofetil
DRUG: Methylprednisolone and azathioprine

Sponsor

Xiaoli Fan